Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma Price to Book Value: 7.134 for Sept. 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 20, 2024 | 7.134 |
| September 19, 2024 | 7.016 |
| September 18, 2024 | 7.016 |
| September 17, 2024 | 7.084 |
| September 16, 2024 | 7.084 |
| September 13, 2024 | 7.192 |
| September 12, 2024 | 6.879 |
| September 11, 2024 | 6.941 |
| September 10, 2024 | 6.613 |
| September 09, 2024 | 6.574 |
| September 06, 2024 | 6.654 |
| September 05, 2024 | 6.525 |
| September 04, 2024 | 6.732 |
| September 03, 2024 | 6.626 |
| August 30, 2024 | 6.626 |
| August 29, 2024 | 6.626 |
| August 28, 2024 | 6.626 |
| August 27, 2024 | 6.705 |
| August 26, 2024 | 6.705 |
| August 23, 2024 | 6.875 |
| August 22, 2024 | 6.955 |
| August 21, 2024 | 7.011 |
| August 20, 2024 | 6.966 |
| August 19, 2024 | 7.077 |
| August 16, 2024 | 7.453 |
| Date | Value |
|---|---|
| August 15, 2024 | 7.203 |
| August 14, 2024 | 7.204 |
| August 13, 2024 | 6.993 |
| August 12, 2024 | 6.611 |
| August 09, 2024 | 6.851 |
| August 08, 2024 | 6.641 |
| August 07, 2024 | 6.625 |
| August 06, 2024 | 6.525 |
| August 05, 2024 | 6.234 |
| August 02, 2024 | 6.909 |
| August 01, 2024 | 6.909 |
| July 31, 2024 | 6.994 |
| July 30, 2024 | 6.958 |
| July 29, 2024 | 6.630 |
| July 26, 2024 | 6.796 |
| July 25, 2024 | 7.133 |
| July 24, 2024 | 6.835 |
| July 23, 2024 | 6.776 |
| July 22, 2024 | 6.672 |
| July 19, 2024 | 6.625 |
| July 18, 2024 | 6.567 |
| July 17, 2024 | 6.625 |
| July 16, 2024 | 7.167 |
| July 15, 2024 | 7.126 |
| July 12, 2024 | 7.098 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.072
Minimum
Oct 01 2019
30.51
Maximum
Dec 07 2022
10.61
Average
7.385
Median
Oct 19 2021
Price to Book Value Benchmarks
| Novo Nordisk AS | 35.14 |
| Eli Lilly and Co | 61.18 |
| Altimmune Inc | 3.630 |
| Genmab AS | 3.646 |
| Viking Therapeutics Inc | 8.486 |
Price to Book Value Related Metrics
| PS Ratio | 153.63 |
| Price | 135.65 |
| Earnings Yield | -1.25% |
| Market Cap | 9.622B |